Valuation: Amgen Inc.

Market Cap 223B 1,116B 199B 186B 168B 317B 21,186B 320B 2,226B 872B 11,018B 838B 820B 35,357B P/E 2026 *
26.2x
P/E 2027 * 23.4x
Enterprise Value 265B 1,322B 236B 220B 200B 376B 25,112B 379B 2,639B 1,033B 13,060B 994B 972B 41,908B EV / Sales 2026 *
6.79x
EV / Sales 2027 * 6.4x
Free-Float
99.77%
Yield 2026 *
2.44%
Yield 2027 * 2.58%
1 day+0.18%
1 week+3.69%
Current month-4.90%
1 month+7.51%
3 months+12.42%
6 months+19.59%
Current year+12.80%
1 week 71.54
Extreme 71.54
75.87
1 month 68.98
Extreme 68.98
80.47
Current year 48.4
Extreme 48.4
83.38
1 year 48.4
Extreme 48.4
83.38
3 years 45.12
Extreme 45.12
83.38
5 years 37.52
Extreme 37.52
83.38
10 years 15.78
Extreme 15.780356
83.38
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Chief Tech/Sci/R&D Officer 57 01/06/2023
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
+0.18%+3.69% - - 223B
-1.36%+0.78%+42.36%+91.48% 1,040B
-5.73%-2.42%+30.23%+58.50% 599B
-2.40%+2.88%+19.13%+85.43% 485B
-2.39%+0.03%+65.67%+36.51% 350B
+0.83%+0.94%+26.97%+44.12% 345B
+1.11%+0.57%+16.01%+38.42% 272B
+0.47%-1.81%-6.11%+9.00% 244B
-1.13%+2.54%+41.19%+45.32% 223B
-1.67%+2.56%+25.13%+90.50% 183B
Average +0.58%+2.38%+28.95%+55.47% 415.87B
Weighted average by Cap. +0.69%+2.31%+32.18%+63.85%

Financials

2026 *2027 *
Net sales 38.97B 195B 34.82B 32.45B 29.42B 55.37B 3,700B 55.8B 389B 152B 1,924B 146B 143B 6,174B 40.39B 202B 36.08B 33.63B 30.49B 57.39B 3,834B 57.84B 403B 158B 1,994B 152B 148B 6,399B
Net income 8.54B 42.69B 7.63B 7.11B 6.45B 12.13B 811B 12.23B 85.18B 33.35B 422B 32.07B 31.37B 1,353B 9.43B 47.12B 8.42B 7.85B 7.12B 13.39B 895B 13.5B 94.02B 36.81B 465B 35.4B 34.62B 1,493B
Net Debt 41.36B 207B 36.94B 34.44B 31.22B 58.75B 3,926B 59.21B 413B 161B 2,042B 155B 152B 6,551B 35.48B 177B 31.69B 29.54B 26.78B 50.4B 3,368B 50.8B 354B 139B 1,751B 133B 130B 5,620B
Projected Income Statement - Annual - Amgen Inc.
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
13/10/26 BRL 74.40 +0.18% 85
09/10/26 BRL 74.27 -0.71% 74
08/10/26 BRL 74.80 +0.92% 1,089
07/10/26 BRL 74.12 +3.30% 63
06/10/26 BRL 71.75 -0.35% 200
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Amgen Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
412.84USD
Average target price
394.77USD
Spread / Average Target
-4.38%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Amgen Inc.